BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//UiO//VTK//NONSGML v1.0//NO
BEGIN:VTIMEZONE
TZID:Europe/Oslo
X-LIC-LOCATION:Europe/Oslo
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:19700329T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:19701025T030000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20261102T211851Z
UID:df5607113473b8e492498e680b6231539c8f2f93
DTSTART;TZID=Europe/Oslo:20261104T161500
DTEND;TZID=Europe/Oslo:20261104T170000
LOCATION:V225, Physics Building
DESCRIPTION:Exploring targeted radiopharmaceutical cancer therapy. Learn h
 ow researchers at Radium Hospital investigate what determines treatment s
 uccess, from cellular uptake and retention to radiation response and dosi
 ng strategies. Featuring examples from prostate and other cancer types, w
 ith short presentations from PhD students.\n\nhttps://www.nnrc.uio.no/akt
 uelt/arrangementer/2026-11-04_asta-juzeniene.html
SUMMARY:LEAD-212 Targeted Alpha Therapy: From Molecular Targets to Treatme
 nt Strategies
URL:https://www.nnrc.uio.no/aktuelt/arrangementer/2026-11-04_asta-juzenien
 e.html
END:VEVENT
END:VCALENDAR